Search research articles
Contact Us
Filters
Showing results (51-60 of 101) with videos related to
Page
of 11
Sort By:
Alzheimer Disease and Associated Disorders
|
January 1, 1992
Growth hormone responses to cholinergically active drugs in patients with dementia of the Alzheimer type
E Lamperti, D Cocchi, E A Parati, et al.
Neurology
|
November 1, 1983
L-dopa long-term treatment in Parkinson's disease: age-related side effects
M Pederzoli, F Girotti, G Scigliano, et al.
Italian Journal of Neurological Sciences
|
April 1, 1997
Increased plasma bilirubin in Parkinson patients on L-dopa: evidence against the free radical hypothesis?
G Scigliano, F Girotti, P Soliveri, et al.
Neurology
|
April 1, 1988
Role of motor performance in cognitive processes of parkinsonian patients
F Girotti, P Soliveri, F Carella, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 1, 1986
Motor and cognitive performances of parkinsonian patients in the on and off phases of the disease
F Girotti, F Carella, M P Grassi, et al.
Italian Journal of Neurological Sciences
|
June 1, 1985
Deprenyl in Parkinson disease: personal experience
P Giovannini, M P Grassi, G Scigliano, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 1, 1977
Altered growth hormone and prolactin responses to dopaminergic stimulation in Huntington's chorea
T Caraceni, A E Panerai, E A Paratl, et al.
Neuroendocrinology
|
January 1, 1979
Growth hormone hyperresponsiveness to dopaminergic stimulation in Huntington's chorea
E E Müller, E A Parati, A E Panerai, et al.
Advances in Neurology
|
January 1, 1984
Bromocriptine and lisuride in Parkinson's disease
T Caraceni, P Giovannini, E Parati, et al.
Italian Journal of Neurological Sciences
|
April 1, 1983
Bromocriptine--lisuride cross tolerance
P Giovannini, G Scigliano, M P Grassi, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 101) with videos related to
Sort By:
Page
of 11
Alzheimer Disease and Associated Disorders
|
January 1, 1992
Growth hormone responses to cholinergically active drugs in patients with dementia of the Alzheimer type
E Lamperti, D Cocchi, E A Parati, et al.
Neurology
|
November 1, 1983
L-dopa long-term treatment in Parkinson's disease: age-related side effects
M Pederzoli, F Girotti, G Scigliano, et al.
Italian Journal of Neurological Sciences
|
April 1, 1997
Increased plasma bilirubin in Parkinson patients on L-dopa: evidence against the free radical hypothesis?
G Scigliano, F Girotti, P Soliveri, et al.
Neurology
|
April 1, 1988
Role of motor performance in cognitive processes of parkinsonian patients
F Girotti, P Soliveri, F Carella, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 1, 1986
Motor and cognitive performances of parkinsonian patients in the on and off phases of the disease
F Girotti, F Carella, M P Grassi, et al.
Italian Journal of Neurological Sciences
|
June 1, 1985
Deprenyl in Parkinson disease: personal experience
P Giovannini, M P Grassi, G Scigliano, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 1, 1977
Altered growth hormone and prolactin responses to dopaminergic stimulation in Huntington's chorea
T Caraceni, A E Panerai, E A Paratl, et al.
Neuroendocrinology
|
January 1, 1979
Growth hormone hyperresponsiveness to dopaminergic stimulation in Huntington's chorea
E E Müller, E A Parati, A E Panerai, et al.
Advances in Neurology
|
January 1, 1984
Bromocriptine and lisuride in Parkinson's disease
T Caraceni, P Giovannini, E Parati, et al.
Italian Journal of Neurological Sciences
|
April 1, 1983
Bromocriptine--lisuride cross tolerance
P Giovannini, G Scigliano, M P Grassi, et al.
Page
of 11